Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.
ReTo Eco-Solutions, Inc. Announces $15M Registered Direct Offering And $10M Concurrent Private Placement
ReTo Eco-Solutions, Inc. (NASDAQ:RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent ecological environments and internet of things technology development services